Amicus Global Research and Gene Therapy Center of Excellence in Philadelphia.
New state of the art research facility builds on the city's 250-year tradition of medical innovation.
We are a biotechnology company at the forefront of advanced therapies to treat a range of devastating rare diseases.
Extraordinary Patient Focus
At Amicus, patient-centricity is in our DNA. See how our commitment to patients goes further than just our medicines and expands out to the rare disease community at large.
News & Announcements
March 19, 2020
First and foremost, your safety and welfare and that of your families always has been and continues to be our number one priority. This is especially true in view of the global COVID-19 outbreak. Amicus remains committed to open and frequent communications to address any questions. We are in this fight together. We will maintain consistent monitoring of this unprecedented situation, provide updates of any changes and remain available to you.